Bifidobacterium longum BL03 (DSM 16603)

Single strain
Single strain

Allergy & Immunology

Respiratory/immune health

Functionality

Supports a healthy response to environmental pathogens [in vitro]

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Visciglia A. et al. Probiotics: a potential therapeutic strategy in respiratory infections. Poster from the 12th Probiotics, Prebiotics & New Foods, Nutraceutical and Botanicals for Nutrition & Human and Mirobiota Health, held in Rome on 12-14 September 2021

For information on blends containing BL03, see the following Blends pages:

  • BL03 + GG + BS01 + BR03™

Gastroenterology

Intestinal Transit/Occasional Constipation

Functionality

Reduces occasional constipation

Supports healthy intestinal transit time

Dosage / Clinical Study

1) 10 billion CFU

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
Clinical studies

1) Del Piano M. et al. The use of probiotics in the treatment of constipation in the elderly (BL03, LP01, BS01, LR05, BA02 and BR03 separately). CIBUS, 2005; 1(1):23-30. doi:10.1097/MCG.0b013e3181ee31c3

For information on blends containing BL03, see the following Blends pages:

  • BL03 + GG + BS01 + BR03™

Pediatrics

HMO Metabolism

Functionality

Selective utilization of human milk oligosaccharides, particularly sialylated HMOs [in vitro]

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Morazzoni et al. Stimulation of Probiotic Bifidobacteirum Strains by Human Milk Oligosaccharides (HMOs) for the Development of Synbiotic Formulas. Poster from the 16th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2023, held in Bratislava on 20-22 June 2023

For information on blends containing BL03, see the following Blends pages:

  • BL03 + GG + BS01 + BR03™

Urology

Oxalate Degradation

Functionality

Supports healthy oxalate metabolism [in vitro]

Available Formats

Single strain

Blend

Finished dosage form

Scientific Support
In vitro studies

a) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

Internal data on anti-inflammatory and antioxidant properties available upon request

For information on blends containing BL03, see the following Blends pages:

  • BL03 + GG + BS01 + BR03™

Associations